Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.82261266 |
2 | neuronal action potential propagation (GO:0019227) | 5.78308351 |
3 | locomotory exploration behavior (GO:0035641) | 5.61125765 |
4 | synaptic vesicle exocytosis (GO:0016079) | 5.59304363 |
5 | vocalization behavior (GO:0071625) | 5.34351310 |
6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.33281028 |
7 | synaptic vesicle maturation (GO:0016188) | 5.28119390 |
8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.15365013 |
9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.03294802 |
10 | glutamate secretion (GO:0014047) | 5.00918783 |
11 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.86131437 |
12 | cellular potassium ion homeostasis (GO:0030007) | 4.82189480 |
13 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.79152117 |
14 | glutamate receptor signaling pathway (GO:0007215) | 4.75737273 |
15 | cerebellar granule cell differentiation (GO:0021707) | 4.63264191 |
16 | neurotransmitter secretion (GO:0007269) | 4.56957308 |
17 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.53206673 |
18 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.51124871 |
19 | sodium ion export (GO:0071436) | 4.49595084 |
20 | synaptic transmission, glutamatergic (GO:0035249) | 4.49337595 |
21 | regulation of synaptic vesicle transport (GO:1902803) | 4.48297061 |
22 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.31291169 |
23 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.30664558 |
24 | positive regulation of synapse maturation (GO:0090129) | 4.30351387 |
25 | protein localization to synapse (GO:0035418) | 4.27765676 |
26 | exploration behavior (GO:0035640) | 4.23561724 |
27 | neuron-neuron synaptic transmission (GO:0007270) | 4.21766297 |
28 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.19556763 |
29 | gamma-aminobutyric acid transport (GO:0015812) | 4.15664575 |
30 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.13910777 |
31 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.13847280 |
32 | response to pheromone (GO:0019236) | 4.07848419 |
33 | neuron cell-cell adhesion (GO:0007158) | 3.97718873 |
34 | long-term memory (GO:0007616) | 3.96384804 |
35 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.94874094 |
36 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.90760576 |
37 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.87704478 |
38 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.80283253 |
39 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.75810863 |
40 | cell communication by electrical coupling (GO:0010644) | 3.75465083 |
41 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.73082009 |
42 | synaptic vesicle endocytosis (GO:0048488) | 3.73008061 |
43 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.71236607 |
44 | long-term synaptic potentiation (GO:0060291) | 3.69981908 |
45 | neurotransmitter transport (GO:0006836) | 3.67599713 |
46 | L-amino acid import (GO:0043092) | 3.65868689 |
47 | positive regulation of membrane potential (GO:0045838) | 3.58280080 |
48 | regulation of postsynaptic membrane potential (GO:0060078) | 3.54444285 |
49 | serotonin metabolic process (GO:0042428) | 3.54067720 |
50 | layer formation in cerebral cortex (GO:0021819) | 3.51390997 |
51 | cell differentiation in hindbrain (GO:0021533) | 3.48038847 |
52 | regulation of synapse structural plasticity (GO:0051823) | 3.47207824 |
53 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.43694463 |
54 | membrane depolarization during action potential (GO:0086010) | 3.43518858 |
55 | regulation of neurotransmitter secretion (GO:0046928) | 3.40418969 |
56 | regulation of synaptic plasticity (GO:0048167) | 3.39686062 |
57 | positive regulation of dendritic spine development (GO:0060999) | 3.39287569 |
58 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.39200826 |
59 | transmission of nerve impulse (GO:0019226) | 3.37985044 |
60 | axon ensheathment in central nervous system (GO:0032291) | 3.36961085 |
61 | central nervous system myelination (GO:0022010) | 3.36961085 |
62 | regulation of synapse maturation (GO:0090128) | 3.36118252 |
63 | detection of calcium ion (GO:0005513) | 3.34855292 |
64 | long term synaptic depression (GO:0060292) | 3.34514455 |
65 | regulation of neurotransmitter levels (GO:0001505) | 3.34508095 |
66 | neuromuscular process controlling posture (GO:0050884) | 3.34298993 |
67 | regulation of vesicle fusion (GO:0031338) | 3.34078420 |
68 | dendritic spine morphogenesis (GO:0060997) | 3.32453728 |
69 | activation of protein kinase A activity (GO:0034199) | 3.31253301 |
70 | regulation of dendritic spine development (GO:0060998) | 3.29551989 |
71 | amino acid import (GO:0043090) | 3.28954500 |
72 | postsynaptic membrane organization (GO:0001941) | 3.27469384 |
73 | neuronal ion channel clustering (GO:0045161) | 3.26821544 |
74 | potassium ion import (GO:0010107) | 3.26059356 |
75 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.25748771 |
76 | primary amino compound metabolic process (GO:1901160) | 3.24290099 |
77 | proline transport (GO:0015824) | 3.23611101 |
78 | presynaptic membrane assembly (GO:0097105) | 3.23116727 |
79 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.22345178 |
80 | membrane depolarization (GO:0051899) | 3.19152879 |
81 | startle response (GO:0001964) | 3.18248835 |
82 | cellular sodium ion homeostasis (GO:0006883) | 3.17060115 |
83 | innervation (GO:0060384) | 3.16843736 |
84 | C4-dicarboxylate transport (GO:0015740) | 3.15356684 |
85 | presynaptic membrane organization (GO:0097090) | 3.14480337 |
86 | neuron recognition (GO:0008038) | 3.12236761 |
87 | potassium ion homeostasis (GO:0055075) | 3.11493128 |
88 | chemosensory behavior (GO:0007635) | 3.08912197 |
89 | regulation of neurotransmitter transport (GO:0051588) | 3.08543568 |
90 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.07388890 |
91 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.06634993 |
92 | synapse assembly (GO:0007416) | 3.02833309 |
93 | fear response (GO:0042596) | 3.00672003 |
94 | synaptic transmission (GO:0007268) | 2.99987154 |
95 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.99385780 |
96 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.99198325 |
97 | membrane hyperpolarization (GO:0060081) | 2.99023097 |
98 | neurotransmitter uptake (GO:0001504) | 2.97627183 |
99 | neuromuscular process controlling balance (GO:0050885) | 2.96085959 |
100 | potassium ion transmembrane transport (GO:0071805) | 2.95323284 |
101 | cellular potassium ion transport (GO:0071804) | 2.95323284 |
102 | auditory behavior (GO:0031223) | 2.93517276 |
103 | behavioral defense response (GO:0002209) | 2.93267310 |
104 | behavioral fear response (GO:0001662) | 2.93267310 |
105 | establishment of synaptic vesicle localization (GO:0097480) | 2.92918321 |
106 | synaptic vesicle transport (GO:0048489) | 2.92918321 |
107 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.90342134 |
108 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.90221638 |
109 | acidic amino acid transport (GO:0015800) | 2.89491082 |
110 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.89106305 |
111 | positive regulation of neurotransmitter transport (GO:0051590) | 2.88991442 |
112 | learning (GO:0007612) | 2.88408506 |
113 | regulation of synaptic transmission (GO:0050804) | 2.88384813 |
114 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.88297320 |
115 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.87218493 |
116 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.86205370 |
117 | glycine transport (GO:0015816) | 2.86067607 |
118 | neuromuscular synaptic transmission (GO:0007274) | 2.85845551 |
119 | adult walking behavior (GO:0007628) | 2.85497500 |
120 | synapse organization (GO:0050808) | 2.84976283 |
121 | axonal fasciculation (GO:0007413) | 2.83980773 |
122 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.82236548 |
123 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.81534022 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.14979913 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.60417021 |
3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.17763119 |
4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.10859864 |
5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.01016587 |
6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.94739958 |
7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.69347275 |
8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.69347275 |
9 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.59133825 |
10 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.56977431 |
11 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.56132391 |
12 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.54064241 |
13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.50610758 |
14 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.49711796 |
15 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.48508226 |
16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.47235697 |
17 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.36637026 |
18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.35733359 |
19 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.31638549 |
20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.21430388 |
21 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.20456831 |
22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.16645547 |
23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.16587587 |
24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.96560230 |
25 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.78764348 |
26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.78609808 |
27 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.78603487 |
28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.76330099 |
29 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.75162507 |
30 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.72852047 |
31 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.71316120 |
32 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.70211221 |
33 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.69865631 |
34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.68717705 |
35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.61437819 |
36 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.56769048 |
37 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.56338521 |
38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.46386783 |
39 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.46258620 |
40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.41140805 |
41 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.36369505 |
42 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33447697 |
43 | P300_19829295_ChIP-Seq_ESCs_Human | 1.31426147 |
44 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.30724895 |
45 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30694198 |
46 | AR_19668381_ChIP-Seq_PC3_Human | 1.29409762 |
47 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.28530992 |
48 | STAT3_23295773_ChIP-Seq_U87_Human | 1.26264752 |
49 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.25172777 |
50 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.23071391 |
51 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.22112507 |
52 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.19724669 |
53 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.19667465 |
54 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19374954 |
55 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.19212740 |
56 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.18730885 |
57 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.18717399 |
58 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.18157381 |
59 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17220504 |
60 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.16055196 |
61 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.15743579 |
62 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.15069544 |
63 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.15041860 |
64 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.14014237 |
65 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.13348408 |
66 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13012166 |
67 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11819364 |
68 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11483931 |
69 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10044837 |
70 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.09823948 |
71 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08964421 |
72 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07457796 |
73 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07350078 |
74 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.07183660 |
75 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.07016787 |
76 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.06858062 |
77 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05702688 |
78 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.04895076 |
79 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.04639261 |
80 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.04639261 |
81 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03632409 |
82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02922720 |
83 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02442945 |
84 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.00887384 |
85 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00609239 |
86 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99534689 |
87 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.99273404 |
88 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.99191972 |
89 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.99099281 |
90 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97502010 |
91 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.97262316 |
92 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.96119888 |
93 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.95658324 |
94 | KDM2B_26808549_Chip-Seq_REH_Human | 0.95631145 |
95 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95316345 |
96 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.95219261 |
97 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.94477323 |
98 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.93704083 |
99 | FUS_26573619_Chip-Seq_HEK293_Human | 0.93258719 |
100 | VDR_22108803_ChIP-Seq_LS180_Human | 0.93071033 |
101 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.92742556 |
102 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92617348 |
103 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92430909 |
104 | KDM2B_26808549_Chip-Seq_K562_Human | 0.92377922 |
105 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.91678305 |
106 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.91043422 |
107 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89397349 |
108 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.89204833 |
109 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88909911 |
110 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88714071 |
111 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.88714071 |
112 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.88675935 |
113 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.88668065 |
114 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87740988 |
115 | TP53_16413492_ChIP-PET_HCT116_Human | 0.86878544 |
116 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.86242096 |
117 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85942367 |
118 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.85221052 |
119 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.84897887 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 6.04963240 |
2 | MP0003880_abnormal_central_pattern | 4.13345305 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.07890145 |
4 | MP0009046_muscle_twitch | 3.64114081 |
5 | MP0004270_analgesia | 3.53858539 |
6 | MP0009745_abnormal_behavioral_response | 3.29039747 |
7 | MP0002064_seizures | 3.18539139 |
8 | MP0002063_abnormal_learning/memory/cond | 3.15621089 |
9 | MP0002272_abnormal_nervous_system | 2.83894751 |
10 | MP0001968_abnormal_touch/_nociception | 2.75639346 |
11 | MP0002572_abnormal_emotion/affect_behav | 2.73525664 |
12 | MP0002734_abnormal_mechanical_nocicepti | 2.63258675 |
13 | MP0009780_abnormal_chondrocyte_physiolo | 2.51307829 |
14 | MP0008569_lethality_at_weaning | 2.48070244 |
15 | MP0001486_abnormal_startle_reflex | 2.44436239 |
16 | MP0002736_abnormal_nociception_after | 2.33556092 |
17 | MP0001501_abnormal_sleep_pattern | 2.33070231 |
18 | MP0004145_abnormal_muscle_electrophysio | 2.30823324 |
19 | MP0001440_abnormal_grooming_behavior | 2.25008632 |
20 | MP0002067_abnormal_sensory_capabilities | 2.19898176 |
21 | MP0005423_abnormal_somatic_nervous | 2.16600761 |
22 | MP0003329_amyloid_beta_deposits | 2.09667965 |
23 | MP0002909_abnormal_adrenal_gland | 1.99010768 |
24 | MP0002735_abnormal_chemical_nociception | 1.98110867 |
25 | MP0002837_dystrophic_cardiac_calcinosis | 1.89971162 |
26 | MP0002184_abnormal_innervation | 1.86797136 |
27 | MP0001970_abnormal_pain_threshold | 1.82058055 |
28 | MP0002733_abnormal_thermal_nociception | 1.80581517 |
29 | MP0003879_abnormal_hair_cell | 1.74016198 |
30 | MP0002557_abnormal_social/conspecific_i | 1.69715242 |
31 | MP0004924_abnormal_behavior | 1.63326049 |
32 | MP0005386_behavior/neurological_phenoty | 1.63326049 |
33 | MP0000013_abnormal_adipose_tissue | 1.62500610 |
34 | MP0005646_abnormal_pituitary_gland | 1.55941851 |
35 | MP0004043_abnormal_pH_regulation | 1.55360971 |
36 | MP0001502_abnormal_circadian_rhythm | 1.52212241 |
37 | MP0001984_abnormal_olfaction | 1.50533825 |
38 | MP0004811_abnormal_neuron_physiology | 1.50225593 |
39 | MP0000955_abnormal_spinal_cord | 1.48195567 |
40 | MP0004858_abnormal_nervous_system | 1.48191327 |
41 | MP0000569_abnormal_digit_pigmentation | 1.48018394 |
42 | MP0002066_abnormal_motor_capabilities/c | 1.45611432 |
43 | MP0008877_abnormal_DNA_methylation | 1.45130052 |
44 | MP0004885_abnormal_endolymph | 1.44029967 |
45 | MP0010386_abnormal_urinary_bladder | 1.43923621 |
46 | MP0003633_abnormal_nervous_system | 1.42450314 |
47 | MP0000778_abnormal_nervous_system | 1.42419495 |
48 | MP0004142_abnormal_muscle_tone | 1.42406273 |
49 | MP0002822_catalepsy | 1.41596290 |
50 | MP0001986_abnormal_taste_sensitivity | 1.34721812 |
51 | MP0002882_abnormal_neuron_morphology | 1.32427832 |
52 | MP0004147_increased_porphyrin_level | 1.23936905 |
53 | MP0005551_abnormal_eye_electrophysiolog | 1.23892696 |
54 | MP0003631_nervous_system_phenotype | 1.23106498 |
55 | MP0000751_myopathy | 1.15978437 |
56 | MP0006276_abnormal_autonomic_nervous | 1.14012351 |
57 | MP0003787_abnormal_imprinting | 1.13703803 |
58 | MP0004215_abnormal_myocardial_fiber | 1.13414035 |
59 | MP0003283_abnormal_digestive_organ | 1.13361221 |
60 | MP0004233_abnormal_muscle_weight | 1.11919466 |
61 | MP0001188_hyperpigmentation | 1.07866547 |
62 | MP0002229_neurodegeneration | 1.06010598 |
63 | MP0003632_abnormal_nervous_system | 1.05697818 |
64 | MP0002152_abnormal_brain_morphology | 1.02609856 |
65 | MP0006072_abnormal_retinal_apoptosis | 1.00092798 |
66 | MP0005167_abnormal_blood-brain_barrier | 0.98163412 |
67 | MP0004742_abnormal_vestibular_system | 0.96628120 |
68 | MP0005645_abnormal_hypothalamus_physiol | 0.96016417 |
69 | MP0002069_abnormal_eating/drinking_beha | 0.95469493 |
70 | MP0002638_abnormal_pupillary_reflex | 0.93151144 |
71 | MP0005535_abnormal_body_temperature | 0.91922650 |
72 | MP0000604_amyloidosis | 0.91462313 |
73 | MP0003183_abnormal_peptide_metabolism | 0.89939116 |
74 | MP0002102_abnormal_ear_morphology | 0.89683821 |
75 | MP0003634_abnormal_glial_cell | 0.86423538 |
76 | MP0002090_abnormal_vision | 0.84831262 |
77 | MP0005499_abnormal_olfactory_system | 0.84322711 |
78 | MP0005394_taste/olfaction_phenotype | 0.84322711 |
79 | MP0008872_abnormal_physiological_respon | 0.83505727 |
80 | MP0001529_abnormal_vocalization | 0.83213887 |
81 | MP0001963_abnormal_hearing_physiology | 0.83205200 |
82 | MP0003122_maternal_imprinting | 0.83154192 |
83 | MP0004484_altered_response_of | 0.82979919 |
84 | MP0004085_abnormal_heartbeat | 0.81073250 |
85 | MP0001905_abnormal_dopamine_level | 0.80796604 |
86 | MP0000920_abnormal_myelination | 0.80173535 |
87 | MP0003137_abnormal_impulse_conducting | 0.78281365 |
88 | MP0003690_abnormal_glial_cell | 0.78235781 |
89 | MP0008961_abnormal_basal_metabolism | 0.76693910 |
90 | MP0004036_abnormal_muscle_relaxation | 0.76564162 |
91 | MP0003646_muscle_fatigue | 0.75948803 |
92 | MP0002876_abnormal_thyroid_physiology | 0.74796687 |
93 | MP0000631_abnormal_neuroendocrine_gland | 0.73173562 |
94 | MP0008874_decreased_physiological_sensi | 0.71633497 |
95 | MP0001177_atelectasis | 0.70776987 |
96 | MP0003121_genomic_imprinting | 0.69792819 |
97 | MP0002653_abnormal_ependyma_morphology | 0.68649142 |
98 | MP0002752_abnormal_somatic_nervous | 0.67868948 |
99 | MP0000026_abnormal_inner_ear | 0.67794244 |
100 | MP0000747_muscle_weakness | 0.67593095 |
101 | MP0001299_abnormal_eye_distance/ | 0.65974121 |
102 | MP0004130_abnormal_muscle_cell | 0.65296998 |
103 | MP0001485_abnormal_pinna_reflex | 0.64068177 |
104 | MP0004510_myositis | 0.63593820 |
105 | MP0003938_abnormal_ear_development | 0.61160748 |
106 | MP0005379_endocrine/exocrine_gland_phen | 0.61056706 |
107 | MP0001765_abnormal_ion_homeostasis | 0.59712451 |
108 | MP0002693_abnormal_pancreas_physiology | 0.59340540 |
109 | MP0003075_altered_response_to | 0.59112554 |
110 | MP0000749_muscle_degeneration | 0.58306964 |
111 | MP0002234_abnormal_pharynx_morphology | 0.56899291 |
112 | MP0005253_abnormal_eye_physiology | 0.56576661 |
113 | MP0001664_abnormal_digestion | 0.56190324 |
114 | MP0003195_calcinosis | 0.56006789 |
115 | MP0003123_paternal_imprinting | 0.52416001 |
116 | MP0010769_abnormal_survival | 0.52040044 |
117 | MP0010770_preweaning_lethality | 0.50188315 |
118 | MP0002082_postnatal_lethality | 0.50188315 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 7.53041542 |
2 | Visual hallucinations (HP:0002367) | 5.95625675 |
3 | Focal seizures (HP:0007359) | 5.43868461 |
4 | Atonic seizures (HP:0010819) | 5.40645199 |
5 | Myokymia (HP:0002411) | 5.38759577 |
6 | Epileptic encephalopathy (HP:0200134) | 5.27350955 |
7 | Febrile seizures (HP:0002373) | 5.03999010 |
8 | Progressive cerebellar ataxia (HP:0002073) | 5.01747172 |
9 | Action tremor (HP:0002345) | 4.82580188 |
10 | Absence seizures (HP:0002121) | 4.70841982 |
11 | Dialeptic seizures (HP:0011146) | 4.09786943 |
12 | Gaze-evoked nystagmus (HP:0000640) | 3.94078806 |
13 | Generalized tonic-clonic seizures (HP:0002069) | 3.91959045 |
14 | Dysdiadochokinesis (HP:0002075) | 3.68459725 |
15 | Broad-based gait (HP:0002136) | 3.62508295 |
16 | Limb dystonia (HP:0002451) | 3.51588516 |
17 | Impaired smooth pursuit (HP:0007772) | 3.47268207 |
18 | Dysmetria (HP:0001310) | 3.37308483 |
19 | Hyperventilation (HP:0002883) | 3.36624041 |
20 | Hemiparesis (HP:0001269) | 3.33817711 |
21 | Truncal ataxia (HP:0002078) | 3.32536262 |
22 | Poor eye contact (HP:0000817) | 3.27542585 |
23 | Diplopia (HP:0000651) | 3.26037317 |
24 | Abnormality of binocular vision (HP:0011514) | 3.26037317 |
25 | Scanning speech (HP:0002168) | 3.23710026 |
26 | Depression (HP:0000716) | 3.21823267 |
27 | Cerebral hypomyelination (HP:0006808) | 3.20256307 |
28 | Supranuclear gaze palsy (HP:0000605) | 3.13197559 |
29 | Impaired social interactions (HP:0000735) | 3.06852331 |
30 | Abnormal social behavior (HP:0012433) | 3.06852331 |
31 | Anxiety (HP:0000739) | 3.06050384 |
32 | Dysmetric saccades (HP:0000641) | 3.03449147 |
33 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.99015025 |
34 | Epileptiform EEG discharges (HP:0011182) | 2.89077330 |
35 | Hemiplegia (HP:0002301) | 2.88091142 |
36 | Intention tremor (HP:0002080) | 2.83284496 |
37 | Genetic anticipation (HP:0003743) | 2.82384388 |
38 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.79952906 |
39 | EEG with generalized epileptiform discharges (HP:0011198) | 2.78522815 |
40 | Amblyopia (HP:0000646) | 2.72447886 |
41 | Status epilepticus (HP:0002133) | 2.71146437 |
42 | Abnormality of the lower motor neuron (HP:0002366) | 2.68767985 |
43 | Hypsarrhythmia (HP:0002521) | 2.60377767 |
44 | Drooling (HP:0002307) | 2.57446494 |
45 | Excessive salivation (HP:0003781) | 2.57446494 |
46 | Ankle clonus (HP:0011448) | 2.54726518 |
47 | Abnormal eating behavior (HP:0100738) | 2.54625798 |
48 | Postural instability (HP:0002172) | 2.54134427 |
49 | Pheochromocytoma (HP:0002666) | 2.52185169 |
50 | Neurofibrillary tangles (HP:0002185) | 2.51328569 |
51 | Cerebral inclusion bodies (HP:0100314) | 2.49575081 |
52 | Agitation (HP:0000713) | 2.40770418 |
53 | Exercise-induced myalgia (HP:0003738) | 2.38960134 |
54 | Polyphagia (HP:0002591) | 2.34459428 |
55 | Postural tremor (HP:0002174) | 2.32501396 |
56 | Gait ataxia (HP:0002066) | 2.30308881 |
57 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.29114846 |
58 | Bradykinesia (HP:0002067) | 2.26928835 |
59 | Ventricular fibrillation (HP:0001663) | 2.25820784 |
60 | Absent speech (HP:0001344) | 2.25335409 |
61 | Neuroendocrine neoplasm (HP:0100634) | 2.22096529 |
62 | Limb ataxia (HP:0002070) | 2.20787063 |
63 | Spastic gait (HP:0002064) | 2.20714887 |
64 | CNS hypomyelination (HP:0003429) | 2.16342668 |
65 | Mutism (HP:0002300) | 2.16221148 |
66 | Spastic tetraplegia (HP:0002510) | 2.11900139 |
67 | Congenital stationary night blindness (HP:0007642) | 2.11484247 |
68 | Megalencephaly (HP:0001355) | 2.09571989 |
69 | Progressive inability to walk (HP:0002505) | 2.09319818 |
70 | Spastic tetraparesis (HP:0001285) | 2.08997681 |
71 | Stereotypic behavior (HP:0000733) | 2.08580582 |
72 | Impaired vibratory sensation (HP:0002495) | 2.07937981 |
73 | Amyotrophic lateral sclerosis (HP:0007354) | 2.07089277 |
74 | Fetal akinesia sequence (HP:0001989) | 2.04598421 |
75 | Tetraplegia (HP:0002445) | 2.02642871 |
76 | Psychosis (HP:0000709) | 2.02318154 |
77 | Abnormality of saccadic eye movements (HP:0000570) | 2.01403798 |
78 | Medial flaring of the eyebrow (HP:0010747) | 2.00267787 |
79 | Urinary urgency (HP:0000012) | 1.99965827 |
80 | Sleep apnea (HP:0010535) | 1.98600196 |
81 | Pancreatic cysts (HP:0001737) | 1.98528310 |
82 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.98425863 |
83 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.98425863 |
84 | Generalized myoclonic seizures (HP:0002123) | 1.95907329 |
85 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.94833565 |
86 | Prolonged QT interval (HP:0001657) | 1.94662567 |
87 | Neuronal loss in central nervous system (HP:0002529) | 1.94041636 |
88 | Abnormality of the corticospinal tract (HP:0002492) | 1.92376368 |
89 | Specific learning disability (HP:0001328) | 1.92349259 |
90 | Delusions (HP:0000746) | 1.89801553 |
91 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.89247090 |
92 | Widely spaced teeth (HP:0000687) | 1.88752552 |
93 | Akinesia (HP:0002304) | 1.86988200 |
94 | Bundle branch block (HP:0011710) | 1.86943254 |
95 | Incomplete penetrance (HP:0003829) | 1.84277816 |
96 | Horizontal nystagmus (HP:0000666) | 1.81248648 |
97 | Increased circulating renin level (HP:0000848) | 1.81029782 |
98 | Lissencephaly (HP:0001339) | 1.80971016 |
99 | Central scotoma (HP:0000603) | 1.80969262 |
100 | Intellectual disability, severe (HP:0010864) | 1.80579145 |
101 | Papilledema (HP:0001085) | 1.79561842 |
102 | Dyskinesia (HP:0100660) | 1.78909056 |
103 | Retinal dysplasia (HP:0007973) | 1.78261241 |
104 | Myotonia (HP:0002486) | 1.77499401 |
105 | Choreoathetosis (HP:0001266) | 1.76929856 |
106 | Abnormal EKG (HP:0003115) | 1.76777094 |
107 | Focal dystonia (HP:0004373) | 1.76358395 |
108 | Lower limb asymmetry (HP:0100559) | 1.75948808 |
109 | Rigidity (HP:0002063) | 1.75456851 |
110 | Split foot (HP:0001839) | 1.75198937 |
111 | Craniofacial dystonia (HP:0012179) | 1.75112803 |
112 | Pancreatic fibrosis (HP:0100732) | 1.74202318 |
113 | True hermaphroditism (HP:0010459) | 1.73870406 |
114 | Hypoplasia of the corpus callosum (HP:0002079) | 1.73637053 |
115 | Progressive microcephaly (HP:0000253) | 1.72785276 |
116 | Spinal canal stenosis (HP:0003416) | 1.72284780 |
117 | Torticollis (HP:0000473) | 1.72209470 |
118 | Peripheral hypomyelination (HP:0007182) | 1.71957160 |
119 | Congenital primary aphakia (HP:0007707) | 1.71628182 |
120 | Gait imbalance (HP:0002141) | 1.71610145 |
121 | Cortical visual impairment (HP:0100704) | 1.71524141 |
122 | Termporal pattern (HP:0011008) | 1.71007834 |
123 | Insidious onset (HP:0003587) | 1.71007834 |
124 | Annular pancreas (HP:0001734) | 1.68937069 |
125 | Clonus (HP:0002169) | 1.66409665 |
126 | Lower limb muscle weakness (HP:0007340) | 1.66343785 |
127 | Inability to walk (HP:0002540) | 1.65477740 |
128 | Protruding tongue (HP:0010808) | 1.64532690 |
129 | Type II lissencephaly (HP:0007260) | 1.63532153 |
130 | Unsteady gait (HP:0002317) | 1.63361566 |
131 | Abnormality of salivation (HP:0100755) | 1.62979261 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 4.37724278 |
2 | EPHA4 | 3.66530990 |
3 | MAP3K4 | 3.39828588 |
4 | MAP3K9 | 3.28394292 |
5 | FRK | 2.84585670 |
6 | RIPK4 | 2.83707692 |
7 | MAP2K7 | 2.72010086 |
8 | MINK1 | 2.42466466 |
9 | CAMKK2 | 2.38747211 |
10 | DAPK2 | 2.29540640 |
11 | PAK6 | 2.26584880 |
12 | MAP2K4 | 2.25521163 |
13 | CASK | 2.10349458 |
14 | MAP3K12 | 1.95024074 |
15 | CAMKK1 | 1.94005687 |
16 | PRKD3 | 1.92031072 |
17 | MARK1 | 1.91083302 |
18 | CDK19 | 1.81954185 |
19 | KSR2 | 1.70212703 |
20 | NTRK2 | 1.67816549 |
21 | NTRK1 | 1.67276779 |
22 | PNCK | 1.63545259 |
23 | PRPF4B | 1.63476213 |
24 | PLK2 | 1.58735034 |
25 | WNK3 | 1.53140133 |
26 | DAPK1 | 1.50713585 |
27 | STK38 | 1.48069631 |
28 | PRKCG | 1.45482149 |
29 | CDK5 | 1.44652858 |
30 | GRK5 | 1.43249555 |
31 | TNIK | 1.35037963 |
32 | BMPR2 | 1.34475302 |
33 | KSR1 | 1.27582825 |
34 | ARAF | 1.23399404 |
35 | PHKG2 | 1.18402581 |
36 | PHKG1 | 1.18402581 |
37 | PINK1 | 1.14665833 |
38 | INSRR | 1.09690636 |
39 | MAP3K2 | 1.09303805 |
40 | RIPK1 | 1.08574677 |
41 | SIK2 | 1.08376159 |
42 | MAP4K2 | 1.07313198 |
43 | UHMK1 | 1.06090034 |
44 | SGK494 | 1.05845902 |
45 | SGK223 | 1.05845902 |
46 | NME1 | 1.02772824 |
47 | OXSR1 | 1.02662791 |
48 | CAMK2A | 1.01175169 |
49 | CSNK1G2 | 1.00841193 |
50 | WNK1 | 1.00521875 |
51 | CAMK1 | 0.96630851 |
52 | MAP3K13 | 0.96074702 |
53 | MAPK13 | 0.95087897 |
54 | CAMK2B | 0.91472955 |
55 | CDK18 | 0.87249678 |
56 | CDK15 | 0.86717791 |
57 | BMPR1B | 0.86688033 |
58 | DYRK1A | 0.85523468 |
59 | SGK2 | 0.85097774 |
60 | PKN1 | 0.83956679 |
61 | TYRO3 | 0.83621645 |
62 | CDK14 | 0.80776538 |
63 | ADRBK2 | 0.79484021 |
64 | GRK1 | 0.78832240 |
65 | PRKCH | 0.78321747 |
66 | PTK2B | 0.77408507 |
67 | STK11 | 0.77081560 |
68 | FES | 0.75653382 |
69 | CDK11A | 0.74385352 |
70 | SGK1 | 0.73035186 |
71 | AKT3 | 0.72821157 |
72 | CCNB1 | 0.72468449 |
73 | FGFR2 | 0.71803095 |
74 | SGK3 | 0.70565866 |
75 | CAMK2D | 0.68123296 |
76 | PDK1 | 0.67994702 |
77 | CAMK2G | 0.67257315 |
78 | PRKCE | 0.66692929 |
79 | STK39 | 0.64819016 |
80 | PDPK1 | 0.64399819 |
81 | RAF1 | 0.63420306 |
82 | PAK3 | 0.63202619 |
83 | CDC42BPA | 0.63199514 |
84 | CSNK1G3 | 0.62804762 |
85 | RET | 0.62393646 |
86 | CAMK1G | 0.60057932 |
87 | TRIM28 | 0.60007257 |
88 | CSNK1A1L | 0.59139049 |
89 | MAP3K1 | 0.57854422 |
90 | DYRK2 | 0.57463248 |
91 | PRKCZ | 0.56761442 |
92 | BCR | 0.56594826 |
93 | WNK4 | 0.54727548 |
94 | NEK6 | 0.53815312 |
95 | RPS6KA3 | 0.51976748 |
96 | BRAF | 0.50714973 |
97 | CSNK1G1 | 0.50567096 |
98 | SCYL2 | 0.50396041 |
99 | FER | 0.50351234 |
100 | MAP3K7 | 0.49352762 |
101 | LIMK1 | 0.48971119 |
102 | SIK3 | 0.48355123 |
103 | MAPK12 | 0.48148324 |
104 | PDK3 | 0.48005778 |
105 | PDK4 | 0.48005778 |
106 | MARK2 | 0.45921531 |
107 | CAMK4 | 0.45758940 |
108 | ROCK2 | 0.44974819 |
109 | MAPK10 | 0.43775648 |
110 | ALK | 0.43179973 |
111 | TNK2 | 0.42414815 |
112 | CSNK1D | 0.41905325 |
113 | FYN | 0.41681201 |
114 | HIPK2 | 0.41238751 |
115 | DMPK | 0.40666219 |
116 | MAP2K6 | 0.40503834 |
117 | PRKACA | 0.40174124 |
118 | LATS2 | 0.40002378 |
119 | CSNK1A1 | 0.38853791 |
120 | MUSK | 0.38316922 |
121 | PRKG1 | 0.37462285 |
122 | MAPKAPK5 | 0.37225907 |
123 | PRKCA | 0.36843894 |
124 | ADRBK1 | 0.35756561 |
125 | EPHA3 | 0.34199160 |
126 | BRSK1 | 0.34135232 |
127 | NUAK1 | 0.33548915 |
128 | STK38L | 0.33195666 |
129 | PRKCB | 0.31467781 |
130 | PRKAA1 | 0.31367696 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.03830339 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.29427753 |
3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.89216308 |
4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.86820538 |
5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.76722931 |
6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.73704596 |
7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.70454177 |
8 | Morphine addiction_Homo sapiens_hsa05032 | 2.44937910 |
9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.42868202 |
10 | Insulin secretion_Homo sapiens_hsa04911 | 2.37196093 |
11 | Salivary secretion_Homo sapiens_hsa04970 | 2.30803124 |
12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.28220881 |
13 | Taste transduction_Homo sapiens_hsa04742 | 2.09171326 |
14 | Long-term depression_Homo sapiens_hsa04730 | 2.07430253 |
15 | Olfactory transduction_Homo sapiens_hsa04740 | 2.06791100 |
16 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.99075257 |
17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.89701162 |
18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.87909730 |
19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.77917407 |
20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.75541096 |
21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.64340518 |
22 | Renin secretion_Homo sapiens_hsa04924 | 1.63185305 |
23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.61862923 |
24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.60103866 |
25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.57008866 |
26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.55732814 |
27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.52839700 |
28 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.39980154 |
29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.32563809 |
30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.31774599 |
31 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.28496416 |
32 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.26741035 |
33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.24369179 |
34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.21588477 |
35 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.20297852 |
36 | Gap junction_Homo sapiens_hsa04540 | 1.18919344 |
37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.17212692 |
38 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.17014495 |
39 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.16874774 |
40 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.08820143 |
41 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.01832114 |
42 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.00842055 |
43 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97163035 |
44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.97044125 |
45 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.96764539 |
46 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93124705 |
47 | * Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87464318 |
48 | Glioma_Homo sapiens_hsa05214 | 0.87313028 |
49 | Melanogenesis_Homo sapiens_hsa04916 | 0.86859928 |
50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81268443 |
51 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.78546366 |
52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.77611494 |
53 | Circadian rhythm_Homo sapiens_hsa04710 | 0.77219099 |
54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76534907 |
55 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.76363284 |
56 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.73739522 |
57 | Alzheimers disease_Homo sapiens_hsa05010 | 0.73711276 |
58 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.73149527 |
59 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.68001134 |
60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67784232 |
61 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67128470 |
62 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66321090 |
63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.66035183 |
64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.65567568 |
65 | Axon guidance_Homo sapiens_hsa04360 | 0.64537454 |
66 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.62933445 |
67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61818765 |
68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61115958 |
69 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59082460 |
70 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58874942 |
71 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57997435 |
72 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.57451041 |
73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56679541 |
74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.56230546 |
75 | Phototransduction_Homo sapiens_hsa04744 | 0.55609052 |
76 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.55471111 |
77 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53855812 |
78 | Bile secretion_Homo sapiens_hsa04976 | 0.50887417 |
79 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.50210403 |
80 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.50031361 |
81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49618051 |
82 | ABC transporters_Homo sapiens_hsa02010 | 0.49129737 |
83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.48714684 |
84 | Histidine metabolism_Homo sapiens_hsa00340 | 0.48305335 |
85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45094579 |
86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42711859 |
87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.42565188 |
88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.42273989 |
89 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.40877253 |
90 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.40192494 |
91 | Mineral absorption_Homo sapiens_hsa04978 | 0.39816159 |
92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.39409964 |
93 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39089233 |
94 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.37280321 |
95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37111522 |
96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.36770106 |
97 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.36525518 |
98 | Alcoholism_Homo sapiens_hsa05034 | 0.36390397 |
99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.34975617 |
100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34795465 |
101 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.34641524 |
102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.34149247 |
103 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.33372331 |
104 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.32490674 |
105 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.32230023 |
106 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.30533597 |
107 | Endocytosis_Homo sapiens_hsa04144 | 0.30487527 |
108 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.28177264 |
109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.27083306 |
110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.26113991 |
111 | Parkinsons disease_Homo sapiens_hsa05012 | 0.24731580 |
112 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.24634769 |
113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.24058557 |
114 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.22607733 |
115 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.21030602 |
116 | Prion diseases_Homo sapiens_hsa05020 | 0.21013662 |
117 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.20843068 |
118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.18557322 |